Short course carbon ion radiation for prostate cancer
Part of Cancer, Kidney & urinary clinical trials.
This trial tests a short course of carbon ion radiation for prostate cancer. It aims to treat the cancer effectively while limiting side effects and shortening treatment time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be a man aged 19 or older.
- Have prostate cancer confirmed by biopsy within the last 6 months.
- Have a PSA test result from before the biopsy.
- Have low or intermediate risk prostate cancer (based on PSA, Gleason score, and tumor stage).
- Be in generally good health (able to care for yourself).
- Have had an MRI of the prostate before the biopsy.
- No prior pelvic radiation or prostate surgery.
- No other cancer in the last 5 years (except certain skin cancers).
- No severe heart, liver, kidney, or bleeding problems within the last 6 months.
- No current urinary infection or inflammation.
- No metal implants that would interfere with the radiation.
- No prior surgery for an enlarged prostate (like TURP or HoLEP).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a shorter course of radiation therapy (hypofractionated radiotherapy) for men who have already had their prostate removed and still have signs of cancer (like rising PSA). The goal is to see if this can help prevent the cancer from coming back.
This trial tests a shorter course of radiation therapy with an extra 'boost' to the most aggressive part of the tumor, combined with hormone therapy, for men with high-risk or locally advanced prostate cancer that has not spread outside the pelvis.
This trial studies a more sped-up radiation schedule for men with certain local prostate cancers, given together with hormone therapy. It aims to keep cancer control while possibly reducing treatment time and making care easier.
This trial tests a high-precision radiation treatment (CyberKnife SBRT) for prostate cancer that is still within the prostate. It aims to see if a very short course of radiation works well with fewer side effects.
This trial studies a type of focused radiation (“ablative radiotherapy”) for prostate tumors considered intermediate- or high-risk. It may help improve control of the cancer while aiming for acceptable side effects.
This trial tests whether a single, high dose of radiation can treat low- to intermediate-risk prostate cancer. It may be a shorter and more convenient option for eligible patients.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.